Receive the latest updates from Matrix Medical in real time to understand product information.

On April 23rd, the first innovation competition of the 2023 Vascular Innovation Forum (VINNOVA) was successfully concluded in Beijing. After fierce competition, the natural vascular stent project of Hangzhou Matrix Medical Technology Co., Ltd. stood out and won the first place.

Professor Guo Wei, the chairman of the conference, the chairman of the Vascular Medicine Special Committee of the Chinese Research Hospital Association, the chairman of the Vascular Device Branch of the China Medical Device Industry Association, and the first medical center of the People's Liberation Army General Hospital, visited the competition to provide guidance and comments. After the meeting, he delivered a speech summarizing the award-winning projects and highlighted the technical innovation difficulties of the award-winning projects of Juzheng Medical, giving expectations for the future development of the projects.

Professor Zhang Wei, the editor in chief of AVS Brief Report and Innovation magazine, introduced the natural vascular stent (NVS) technology at the 2021 VINNOVA Vascular Innovation Forum. After two years, Matrix Medical, as the first company in China to master intravascular photochemical crosslinking technology, was fortunate to share the latest progress of this project with Professor Zhang Wei and once again receive recognition and encouragement from the professor for its innovative prospects.

About the Vascular Innovation Forum（VINNOVA）

The Vascular Innovation Forum (VINNOVA) is jointly organized by the Vascular Medicine Professional Committee of the Chinese Research Hospital Association, the Vascular Device Branch of the Chinese Medical Device Industry Association, the Beijing Borui Vascular Health Public Welfare Foundation, the Annual of Vascular Surgery, Brief Reports and Innovations magazine, and the China Medical Innovation Alliance.

Since the first edition was held in 2016, adhering to the design intention of "building a common communication platform for clinical experts, research institutes, policy makers, and industry", we have focused on exploring cutting-edge diagnosis and treatment technologies, innovative policies, and innovative transformation processes for vascular diseases, providing new exploration directions for pioneers and forming an important influence in China.